76-5-113. Surreptitious administration of certain substances -- Definitions --
Penalties -- Defenses.
(1) As used in this section:
(a) "Administer" means the introduction of a substance into the body by injection,
inhalation, ingestion, or by any other means.
(b) "Alcoholic beverage" has the same meaning as "alcoholic beverage" in Section
32A-1-105.
(c) "Bodily injury" has the same definition as in Section 76-1-601.
(d) "Controlled substance" has the same definition as in Section 58-37-2.
(e) "Deleterious substance" means a substance which, if administered, would likely cause
bodily injury.
(f) "Poisonous" means a substance which, if administered, would likely cause serious
bodily injury or death.
(g) "Prescription drug" has the same definition as in Section 58-17b-102.
(h) "Serious bodily injury" has the same definition as in Section 19-2-115.
(i) "Substance" means a controlled substance, poisonous substance, or deleterious
substance as defined in this Subsection (1).
(2) In addition to any other offense the actor's conduct may constitute, it is a criminal
offense for a person, surreptitiously or by means of fraud, deception, or misrepresentation, to
cause another person to unknowingly consume or receive the administration of:
(a) any poisonous, deleterious, or controlled substance; or
(b) any alcoholic beverage.
(3) A violation of Subsection (2) is:
(a) a second degree felony if the substance is a poisonous substance, regardless of
whether the substance is a controlled substance or a prescription drug;
(b) a third degree felony if the substance is not within the scope of Subsection (3)(a), and
is a controlled substance or a prescription drug; and
(c) a class A misdemeanor if the substance is a deleterious substance or an alcoholic
beverage.
(4) (a) It is an affirmative defense to a prosecution under Subsection (2) that the actor:
(i) provided the appropriate administration of a prescription drug; and
(ii) acted on the reasonable belief that his conduct was in the best interest of the
well-being of the person to whom the prescription drug was administered.
(b) (i) The defendant shall file and serve on the prosecuting attorney a notice in writing
of his intention to claim a defense under Subsection (4)(a) not fewer than 20 days before the trial.
(ii) The notice shall specifically identify the factual basis for the defense and the names
and addresses of the witnesses the defendant proposes to examine to establish the defense.
(c) The prosecuting attorney shall file and serve the defendant with a notice containing
the names and addresses of the witnesses the prosecutor proposes to examine in order to
contradict or rebut the defendant's claim of an affirmative defense under Subsection (4)(a). This
notice shall be filed or served not more than ten days after receipt of the defendant's notice under
Subsection (4)(b), or at another time as the court may direct.
(d) (i) Failure of a party to comply with the requirements of Subsection (4)(b) or (4)(c)
entitles the opposing party to a continuance to allow for preparation.
(ii) If the court finds that a party's failure to comply is the result of bad faith, it may
impose appropriate sanctions.
(5) This section does not diminish the scope of authorized health care by a health care
provider as defined in Section 26-23a-1.
Amended by Chapter 317, 2008 General Session
Amended by Chapter 391, 2008 General Session
Download Code Section Zipped WordPerfect 76_05_011300.ZIP 3,367 Bytes
Sections in this Chapter|Chapters in this Title|All Titles|Legislative Home Page
Last revised: Wednesday, July 23, 2008